Prescription drugs; price transparency. (HB876)

Introduced By

Del. Suhas Subramanyam (D-Sterling) with support from co-patrons Del. Chris Hurst (D-Blacksburg), and Del. Shelly Simonds (D-Newport News)

Progress

Introduced
Passed Committee
Passed House
Passed Senate
Signed by Governor
Became Law

Description

Prescription drug price transparency. Requires every health carrier, pharmacy benefits manager, wholesale drug distributer, and drug manufacturer to report information about prescription drug prices and related information to the Department of Health and requires the Department to make such information available on its website. Read the Bill »

Outcome

Bill Has Failed

History

DateAction
01/07/2020Committee
01/07/2020Prefiled and ordered printed; offered 01/08/20 20104912D
01/07/2020Referred to Committee on Health, Welfare and Institutions
01/17/2020Assigned HWI sub: Health Professions
01/29/2020Impact statement from DPB (HB876)
01/30/2020House committee, floor amendments and substitutes offered
01/30/2020Subcommittee recommends continuing to 2021
02/04/2020Continued to 2021 in Health, Welfare and Institutions
02/04/2020Continued to 2021 with substitute in Health, Welfare and Institutions

Post a Public Comment About this Bill



if you have one


(Limited HTML is OK: <a>, <em>, <strong>, <s>)